Wilmington Trust National Association’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$4.54M Sell
55,942
-1,353
-2% -$106K 0.16% 134
2014
Q1
$4.37M Sell
57,295
-3,190
-5% -$232K 0.16% 130
2013
Q4
$4.36M Buy
60,485
+3,804
+7% +$264K 0.16% 125
2013
Q3
$3.9M Buy
56,681
+6,825
+14% +$452K 0.16% 127
2013
Q2
$3.16M Buy
+49,856
New +$3.24M 0.14% 136

Other funds holding NVS

Wilmington Trust National Association's NVS Position: Q2 2014 in Review

Wilmington Trust National Association reduced its Novartis (NVS) stake by 2.4% in Q2 2014, selling an estimated $106K and leaving 55,942 shares worth $4.54M. The position accounts for 0.16% of the portfolio, ranked #134.

Wilmington Trust National Association first reported a position in NVS in Q2 2013 and has held it in 5 quarters since. 848 funds tracked by Wall St. Rank hold NVS as of Q2 2014.

  • Wilmington Trust National Association held 55,942 shares of Novartis worth $4.54M as of Q2 2014.
  • Wilmington Trust National Association sold 1,353 Novartis shares in Q2 2014, an estimated $106K.
  • Novartis made up 0.16% of Wilmington Trust National Association's portfolio in Q2 2014, its #134 holding.
  • Wilmington Trust National Association first reported a position in Novartis in Q2 2013 and has held it in 5 quarters since.
  • 848 funds tracked by Wall St. Rank held Novartis as of Q2 2014.

Based on Wilmington Trust National Association's 13F filing for Q2 2014, filed 13 Aug 2014.